Search
for

    Glossary Bexarotene

    medication used to treat certain types of skin cancer

    Bexarotene is a medication primarily used to treat cutaneous T-cell lymphoma, a type of skin cancer. It works by activating retinoid X receptors, which help regulate cell growth and differentiation. While it is not specifically used for hair loss or alopecia, its effects on cell growth have been studied in various contexts, including dermatological conditions.

    Research 10 of 103

    1. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata Journal of the American Academy of Dermatology · 2009 · 44 citations
    2. Bexarotene gel: A new topical therapy for alopecia areata International journal of trichology · 2010 · 4 citations
    3. Results of stage I in a phase II randomized bilateral comparison of bexarotene 1% topical gel in alopecia areata Journal of the American Academy of Dermatology · 2005
    4. Alopecia Areata: An Evidence-Based Treatment Update American journal of clinical dermatology · 2014 · 72 citations
    5. Review of treatment for alopecia totalis and alopecia universalis International Journal of Dermatology · 2017 · 44 citations
    6. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome Journal of The American Academy of Dermatology · 2010 · 39 citations
    7. Current management strategies for cutaneous T-cell lymphoma Clinics in Dermatology · 2004 · 39 citations
    8. Topical and intralesional therapies for alopecia areata Dermatologic therapy · 2011 · 36 citations
    9. CD8+ mycosis fungoides clinically masquerading as alopecia areata Journal of Cutaneous Pathology · 2016 · 8 citations
    10. Follicular Mycosis Fungoides: Variability of a Rare Entity SKINmed Dermatology for the Clinician · 2005 · 8 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →